弗洛國際 FLOW 深 滬
已收盤 09-26 16:00:00 美东时间
35.0089
+0.400
+1.16%
華盛通- 最 高35.05
- 今 開35.02
- 成交量 1725股
- 最 低 35.0005
- 昨 收 34.6087
- 總市值 1260.32万
- 52周最高 35.19
- 市盈率 靜 22.02
- 換手率 0.48%
- 52周最低 25.748
- 委 比 0.00%
- 總股本 36.00万
- 歷史最高 35.19
- 量 比 1.18
- 振 幅 0.14%
- 歷史最低 23.6998
- 每 手 1
- 風險率 1.95%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多bioAffinity Technologies shares are trading higher after the company announced it received a notice of allowance for a U.S. patent titled "DETECTION OF EARLY-STAGE LUNG CANCER IN SPUTUM USING AUTOMATED FLOW CYTOMETRY AND MACHINE LEARNING"
bioAffinity Technologies shares are trading higher after the company announced ...
09-13 04:08
Flow Beverage Corp. Announces Restructuring Agreement with Lenders
Flow Beverage Corp. ( ($TSE:FLOW) ) just unveiled an update. Flow Beverage Corp...
09-02 19:46
Velo3D to Ring Nasdaq Opening Bell on August 27, 2025
FREMONT, Calif., Aug. 26, 2025 /PRNewswire/ -- Velo3D, Inc. (Nasdaq: VELO), a leader in additive manufacturing (AM) technology known for transforming aerospace and defense supply chains thro...
08-26 21:00
依托北极星数字智能架构，极狐T1定义精品纯电新标杆
中国经济新闻网讯（刘晨曦）8月22日，北汽极狐正式发布“北极星数字智能架构”，并开启极狐T1的预售。新车共推出5款车型，预售价格区间为6.88万至9.38万元...
08-25 10:14
Ozempic Gains First Approval In Canada For Kidney Disease And Cardiovascular Death Risk
Health Canada approved Ozempic for type 2 diabetes patients with chronic kidney disease after positive FLOW trial results.
08-20 01:25
太盟投资，接手中国最大商业地产运营商
（来源：不良资产行业观研） 近期，据珠海万达内部通知，肖广瑞因个人原因辞去大连新达盟及珠海万达商管首席执行官职务。 同时，任命黄德炜和胡正伟共同担任...
08-13 18:45
FGI INDUSTRIES ANNOUNCES SECOND QUARTER 2025 RESULTS
EAST HANOVER, N.J., Aug. 11, 2025 /PRNewswire/ -- FGI Industries Ltd. (Nasdaq: FGI) ("FGI" or the "Company"), a leading global supplier of kitchen and bath products, today announced results ...
08-12 04:15
Flow Beverage Corp. Completes $6 Million Funding with RI Flow LLC
Flow Beverage Corp. ( ($TSE:FLOW) ) has provided an update. Flow Beverage Corp....
08-09 05:45
LIONSGATE REPORTS RESULTS FOR FIRST QUARTER FISCAL 2026
Studio Revenue was $556 Million; Net Loss From Continuing Operations Attributable to Shareholders was $94.0 Million or $0.35 Diluted Net Loss Per Share Adjusted Net Loss from Continuing Oper...
08-08 04:05
诺和诺德2025Q2业绩电话会高管解读财报
拉尔斯·弗鲁尔加德·约根森 2025年前六个月，我们的销售额增长了18%，营业利润增长了29%。正如上周宣布的那样，诺和诺德已下调2025年全年业绩预期，较今年...
08-07 10:45
